Elevance Health closed at $434.18 on Nov 4, up 4.94%, 2.5% below its 52-week closing high. Volume of 1.7M shares was 1.21× its 20-day average (close to normal).
Split-adjusted performance: +8.5% over one month, +15.9% over six months, +38.6% over one year.
In the quarter ended Sep 30, 2026, revenue was $51.43B, up 1.4% from a year earlier, with a net margin of 2.7%.
Short interest was 5.1M shares at the Oct 15 settlement, up 5.8% from the prior report (2.4% of float, 4.0 days to cover).